SCHEMBL25877127

SCHEMBL25877127

OCc1ccc(Oc2c(Oc3ccccc3)c(-c3cccs3)c3nsnc3c2-c2cccs2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.48
TOP2A P11388 1/20 0.39
TOP2B Q02880 1/20 0.39
TTR P02766 1/20 0.36
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35
FYN P06241 2/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
MAPT P10636 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HTR2B P41595 1/20 0.32
MTNR1A P48039 1/20 0.32
MTNR1B P49286 1/20 0.32
ALDH1A1 P00352 3/20 0.32
NPBWR1 P48145 1/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17629885 0.88 MAPT (0.36) LTA4HMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL18871951 0.86 DPP4 (0.36) TOP2ATOP2BMAPTNPC1RAB9A
SCHEMBL18839910 0.84 LTA4H (0.44) LTA4HMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL18871725 0.84 ALDH1A1 (0.47) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL18871724 0.84 ALDH1A1 (0.34) PPARGMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL17629968 0.83 BTK (0.37) PPARGPPARAMAPTNPC1RAB9A
SCHEMBL18871723 0.83 ALDH1A1 (0.36) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL18839941 0.83 SRD5A2 (0.44) TTRMAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL22470187 0.81 ACHE (0.34) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL18839885 0.81 CYP19A1 (0.38) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713314-B2 Disubstituted diaryloxybenzoheterodiazole compounds ENI S.P.A. (IT) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713314-B2 Disubstituted diaryloxybenzoheterodiazole compounds SCO2, NR3C2, CBR3 LTA4H 4344/4885TOP2A 2850/4885TOP2B 2174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.